Financial Value
Pillar VIs there a paid market, and can this company reach it with the capital it has?
- Addressable market and payer dynamics
- Reimbursement path and code status
- Revenue model and pricing power
- Capital efficiency and runway
ROV scores a health or life science company 0 to 10 on four pillars. Each pillar is a set of named metrics. Each metric's input is traced to a cited source. It is a company-quality score, not a fit score. Fit is computed separately, for each fund's mandate.
Built by healthcare investment operators. Clinical evidence, the regulatory path and the payer landscape are scored on their own terms, not folded into a generic growth model.
Is there a paid market, and can this company reach it with the capital it has?
Does it change an outcome that matters, and how mature is the evidence that it does?
Have these people done this before, and is the clinical and commercial judgment in the room?
Is it new, is it protected, and is the path to clearance clear?
A scorecard shows every metric, its input, its rule and its source.